Retatrutide is a novel medication generating significant buzz in the weight loss field. This remarkable peptide, developed by Eli Lilly, functions as a combined GIP and GLP-1 target agonist. Essentially, it replicates the action of these body's hormones, which regulate appetite and promote feelings of fullness. Clinical studies have indicated promi